A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis

NCT06998693 · clinicaltrials.gov ↗

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Ul

Interventions

DRUG: 5-ASA (5-Aminosalicylate)
PROCEDURE: Colon Endoscopy Procedure
DIAGNOSTIC_TEST: Blood Routine Test at 4-week
DIAGNOSTIC_TEST: Blood Routine Test at 8-week
DIAGNOSTIC_TEST: Blood Routine Test at 12-week
DIAGNOSTIC_TEST: Stool Routine Test at 4-week
DIAGNOSTIC_TEST: Stool Routine Test at 8-week
DIAGNOSTIC_TEST: Stool Routine Test at 12-week
DIAGNOSTIC_TEST: Erythrocyte Sedimentation Rate Test at 4-week
DIAGNOSTIC_TEST: Erythrocyte Sedimentation Rate Test at 8-week
DIAGNOSTIC_TEST: Erythrocyte Sedimentation Rate Test at 12-week
DIAGNOSTIC_TEST: C-reactive Protein Test at 4-week
DIAGNOSTIC_TEST: C-reactive Protein Test at 8-week
DIAGNOSTIC_TEST: C-reactive Protein Test at 12-week
DIAGNOSTIC_TEST: Liver Function Test at 4-week
DIAGNOSTIC_TEST: Liver Function Test at 8-week
DIAGNOSTIC_TEST: Liver Function Test at 12-week
DIAGNOSTIC_TEST: Kidney Function Test at 4-week
DIAGNOSTIC_TEST: Kidney Function Test at 8-week
DIAGNOSTIC_TEST: Kidney Function Test at 12-week

Sponsor

Xijing Hospital of Digestive Diseases